Macrogenics (MGNX) Income towards Parent Company (2012 - 2026)

Macrogenics (MGNX) has reported Income towards Parent Company for 15 consecutive years, with -$38.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income towards Parent Company rose 8.91% year-over-year to -$38.9 million; the TTM figure through Mar 2026 stood at -$72.5 million (down 26.04% YoY), while the FY2025 annual figure was -$74.6 million, down 11.39% from the prior year.
• Income towards Parent Company declined to -$38.9 million in Q1 2026 per MGNX's latest filing, from -$14.1 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $56.3 million in Q3 2024 and bottomed at -$100.2 million in Q1 2024.
• Historically, Income towards Parent Company has averaged -$31.2 million across 5 years, with a median of -$38.9 million in 2026.
• Annual changes were most pronounced in 2023 — Income towards Parent Company plunged 511.87% — and 2024, when it surged 258.61%.
• Macrogenics' Income towards Parent Company stood at $12.0 million in 2022, then slumped by 511.87% to -$49.4 million in 2023, then soared by 68.75% to -$15.4 million in 2024, then advanced by 8.39% to -$14.1 million in 2025, then tumbled by 175.42% to -$38.9 million in 2026.
• Business Quant data shows MGNX's Income towards Parent Company at -$38.9 million in Q1 2026, -$14.1 million in Q4 2025, and $16.8 million in Q3 2025.